Human IL-22 Protein (Human IL-22, His Tag) Ala 34 - Ile 179 (Accession # Q9GZX6) was produced in human 293 cells (HEK293) at ACROBiosystems.
Human IL-22, His Tag is fused with a polyhistidine tag at the N-terminus, and has a calculated MW of 17.6 kDa. The predicted N-terminus is His. DTT-reduced Protein migrates as 21-33 kDa in SDS-PAGE due to glycosylation.
Less than 1.0 EU per μg of the Human IL-22, His Tag by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Interleukin-22 (IL22) is also known as cytokine Zcyto18, IL-10-related T-cell-derived-inducible factor (IL-TIF), which is belongs to the IL-10 family or IL-10 superfamily (including IL-19, IL-20, IL-24, and IL-26), a class of potent mediators of cellular inflammatory responses. IL-22 is produced by activated DC and T cells and initiates innate immune responses against bacterial pathogens especially in epithelial cells such as respiratory and gut epithelial cells. IL-22 biological activity is initiated by binding to a cell-surface complex composed of IL-22R1 and IL-10R2 receptor chains and further regulated by interactions with a soluble binding protein IL-22BP. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.